SynEry

SynEry develops synthetic blood cells as an alternative to natural blood products to address global blood supply instabilities.[1]

Overview

SynEry aims to create synthetic erythrocytes in advanced lipid vesicles to address scarcity and safety issues in blood supply, particularly in low- and middle-income countries. The project has received funding from the Horizon Europe programme under grant agreement No 101046894.

Something wrong or missing? Send an update. Fixed within 24 hours.